Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitochondrial
AAA
(ATPases Associated with diverse cellular Activities) proteases i-
AAA
(intermembrane space-
AAA
) and m-
AAA
(matrix-
AAA
) are closely related and have major roles in inner membrane protein homeostasis. Mutations of m-
AAA
proteases are associated with neuromuscular disorders in humans. However, the role of i-
AAA
in metazoans is poorly understood. We generated a deletion affecting Drosophila i-
AAA
, dYME1L (dYME1L(del)). Mutant flies exhibited premature aging, progressive locomotor deficiency and neurodegeneration that resemble some key features of m-
AAA
diseases. dYME1L(del) flies displayed elevated mitochondrial unfolded protein stress and irregular cristae. Aged dYME1L(del) flies had reduced complex I (NADH/
ubiquinone
oxidoreductase) activity, increased level of reactive oxygen species (ROS), severely disorganized mitochondrial membranes and increased apoptosis. Furthermore, inhibiting apoptosis by targeting dOmi (Drosophila Htra2/Omi) or DIAP1, or reducing ROS accumulation suppressed retinal degeneration. Our results suggest that i-
AAA
is essential for removing unfolded proteins and maintaining mitochondrial membrane architecture. Loss of i-
AAA
leads to the accumulation of oxidative damage and progressive deterioration of membrane integrity, which might contribute to apoptosis upon the release of proapoptotic molecules such as dOmi. Containing ROS level could be a potential strategy to manage mitochondrial
AAA
protease deficiency.
...
PMID:Loss of Drosophila i-AAA protease, dYME1L, causes abnormal mitochondria and apoptotic degeneration. 2616 69